MVP

3.57%

40.5¢ medical developments international limited

Does anyone know how much they cost?

First 8 Last

Share
Profile

Follow
BD3099

1,067 Posts.

78

26/07/24

14:10

Post #: 74933019
Share

Originally posted by gragou02: ↑

The chairman and ceo need to be held account at the next AGM. correct me if I'm wrong but is the value of the company is down about 90% since this ceo has been in charge?Yeah, you may be just about right with respect to price drop since the new team took over. But I'm not convinced that they're totally to blame. That share price lived above $10 for a period in early 2020 just before Covid was recognised.
It was buoyed by the undoubted success of the green whistle which proved, over many examples, just how effective it was for people in pain. Not only that but it was a pain killer that was a non-opioid which was an extremely acceptable story to present to the world.

As time has gone by, the new team has had to dismantle many of the aspirations that drove the initial excitement, They've had to change their approach to the relatively anemic marketing attempts to generate sales across several of the world's areas.
Nothing has really worked so far and nothing was included in this Capital raise request to suggest otherwise. They talked about cost efficiencies and margin improvement, which are normally healthy signs for shareholders, but what was missing was any serious attempt to talk about revenue growth and this is what is needed here at this stage.

From what I've read, "hospital" reports confirm that the green whistle is effective and quick to take effect but it's considered to be very expensive.
And, my guess is that therein lies the problem.
You can have a great product but, sometimes, they're not commercially viable on a large scale.

Maybe it is managements poor performance but maybe it's the business model. Selling an expensive solution into hospitals around the world when hospitals around the world are struggling with budget cuts, demanded by Governments floundering in debt, may be at the heart of the problem.

Expand

Does anyone know how much they cost?

MVP Price at posting: 48.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

HLX

Helix investor makes partial takeover bid, proposing board changes

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

There are more pages in this discussion • 13 more messages in this thread...

First 8 Last

Add MVP (ASX) to my watchlist

(20min delay)
Last 40.5¢		Change -0.015(3.57%)		Mkt cap ! $45.62M

Open	High	Low	Value	Volume
42.0¢	43.5¢	40.5¢	$57.24K	137.9K

Buyers (Bids)

No.	Vol.	Price($)
2	11372	40.5¢

Sellers (Offers)

Price($)	Vol.	No.
44.0¢	8392	1

View Market Depth

No.	Vol.	Price($)
2	11372	0.405
4	103000	0.400
3	68653	0.390
3	15352	0.385
4	17110	0.380

Price($)	Vol.	No.
0.440	8392	1
0.450	4458	1
0.465	10494	2
0.470	61451	4
0.475	18010	1

Last trade - 16.10pm 30/08/2024 (20 minute delay)

MVP (ASX) Chart

Does anyone know how much they cost?

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Lendlease sells off US east coast construction operations in latest global divestment push

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Helix investor makes partial takeover bid, proposing board changes

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Does anyone know how much they cost?

Top Stories

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Lendlease sells off US east coast construction operations in latest global divestment push

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Helix investor makes partial takeover bid, proposing board changes

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News